|
biomedicina slovenica |
pr=Berkhof : 7
-
Arbyn Marc; Canfell Karen; Poljak Mario; Berkhof Johannes; de Sanjosé Silvia; Wentzensen Nicolas
HPV mRNA testing in cervical cancer screening
2022 ►
-
Arbyn Marc; Simon Marie; Peeters Eliana; Xu Lan; Meijer Chris J.L.M.; Berkhof Johannes; Cuschieri Kate S.; Bonde Jesper; Oštrbenk Valenčak Anja; Poljak Mario
2020 list of human papillomavirus assays suitable for primary cervical cancer screening
2021 ►
-
Rossi Paolo Giorgi; Ronco Guglielmo; Dillner J.; Elfström K. Miriam; Snijders Peter .J.F.; Arbyn Marc; Berkhof Johannes; Carozzi Francesca; Del Mistro Annarosa; Poljak Mario
Why follow-back studies should be interpreted cautiously
2016 ►
-
Kocjan Boštjan; Bzhalava D.; Forslund O.; Berkhof Johannes; Dillner J.; Poljak Mario
Molecular methods for identification and characterization of novel papillomaviruses
2015 ►
-
Arbyn Marc; Snijders P.J.F.; Meijer C. J. L. M.; Berkhof Johannes; Cuschieri Kate S.; Kocjan Boštjan; Poljak Mario
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
2015 ►
-
Poljak Mario; Rogovskaya Svetlana; Kesić Vesna; Bray Freddie; Berkhof Johannes; Seme Katja; Brotons Maria; Castellsagué Xavier; Syrjänen Stina; Arbyn Marc; Bosch Francesc Xavier
Recommendations for cervical cancer prevention in Central and Eastern Europe and Central Asia
2013 ►
-
Hesselink A. T.; Meijer C. J. L. M.; Poljak Mario; Berkhof J.
Clinical validation of the Abbott RealTime High Risk (HR) HPV assay according to the guidelines for HPV DNA test requirements for cervical screening
2013 ►
New search
Comments
Top of page
Institute for Biostatistics and Medical Informatics